Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin-Fa Wang

Showing results (381-390 of 433) with videos related to

Pageof 44
Sort By:
Human Vaccines & Immunotherapeutics|May 5, 2026
NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variantsXuan Ying Poh, Shirley Y Y Mah, Aileen Y Y Yeoh, et al.
Virologica Sinica|March 2, 2019
Correction to: Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in KenyaSheila Ommeh, Wei Zhang, Ali Zohaib, et al.
Nature Communications|January 18, 2024
Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severityQuy Xiao Xuan Lin, Deepa Rajagopalan, Akshamal M Gamage, et al.
Virologica Sinica|December 21, 2018
Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in KenyaSheila Ommeh, Wei Zhang, Ali Zohaib, et al.
The Lancet. Infectious Diseases|February 7, 2020
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 studyElliott Geoffrey Playford, Trent Munro, Stephen M Mahler, et al.
Iscience|October 10, 2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2Phillip Pymm, Samuel J Redmond, Olan Dolezal, et al.
Infection Ecology & Epidemiology|May 7, 2016
The equine Hendra virus vaccine remains a highly effective preventative measure against infection in horses and humans: 'The imperative to develop a human vaccine for the Hendra virus in Australia'Alison J Peel, Hume E Field, Peter A Reid, et al.
The Lancet. Infectious Diseases|November 5, 2020
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort studyOon Tek Ng, Kalisvar Marimuthu, Vanessa Koh, et al.
Science (New York, N.Y.)|December 22, 2012
Comparative analysis of bat genomes provides insight into the evolution of flight and immunityGuojie Zhang, Christopher Cowled, Zhengli Shi, et al.
The Lancet. Microbe|March 29, 2021
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal studyWan Ni Chia, Feng Zhu, Sean Wei Xiang Ong, et al.
Pageof 44

Showing results (381-390 of 433) with videos related to

Sort By:
Pageof 44
Human Vaccines & Immunotherapeutics|May 5, 2026
NVX-CoV2372, monovalent mRNA and bivalent mRNA vaccines elicit broadly cross-reactive antibodies against emerging SARS-CoV-2 variantsXuan Ying Poh, Shirley Y Y Mah, Aileen Y Y Yeoh, et al.
Virologica Sinica|March 2, 2019
Correction to: Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in KenyaSheila Ommeh, Wei Zhang, Ali Zohaib, et al.
Nature Communications|January 18, 2024
Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severityQuy Xiao Xuan Lin, Deepa Rajagopalan, Akshamal M Gamage, et al.
Virologica Sinica|December 21, 2018
Genetic Evidence of Middle East Respiratory Syndrome Coronavirus (MERS-Cov) and Widespread Seroprevalence among Camels in KenyaSheila Ommeh, Wei Zhang, Ali Zohaib, et al.
The Lancet. Infectious Diseases|February 7, 2020
Safety, tolerability, pharmacokinetics, and immunogenicity of a human monoclonal antibody targeting the G glycoprotein of henipaviruses in healthy adults: a first-in-human, randomised, controlled, phase 1 studyElliott Geoffrey Playford, Trent Munro, Stephen M Mahler, et al.
Iscience|October 10, 2022
Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2Phillip Pymm, Samuel J Redmond, Olan Dolezal, et al.
Infection Ecology & Epidemiology|May 7, 2016
The equine Hendra virus vaccine remains a highly effective preventative measure against infection in horses and humans: 'The imperative to develop a human vaccine for the Hendra virus in Australia'Alison J Peel, Hume E Field, Peter A Reid, et al.
The Lancet. Infectious Diseases|November 5, 2020
SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort studyOon Tek Ng, Kalisvar Marimuthu, Vanessa Koh, et al.
Science (New York, N.Y.)|December 22, 2012
Comparative analysis of bat genomes provides insight into the evolution of flight and immunityGuojie Zhang, Christopher Cowled, Zhengli Shi, et al.
The Lancet. Microbe|March 29, 2021
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal studyWan Ni Chia, Feng Zhu, Sean Wei Xiang Ong, et al.
Pageof 44